The store will not work correctly when cookies are disabled.
N-(5-bromo-6-methylpyrazin-2-yl)-3-(trifluoromethyl)benzamide
ID: ALA4096177
PubChem CID: 137655485
Max Phase: Preclinical
Molecular Formula: C13H9BrF3N3O
Molecular Weight: 360.13
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc(NC(=O)c2cccc(C(F)(F)F)c2)cnc1Br
Standard InChI: InChI=1S/C13H9BrF3N3O/c1-7-11(14)18-6-10(19-7)20-12(21)8-3-2-4-9(5-8)13(15,16)17/h2-6H,1H3,(H,19,20,21)
Standard InChI Key: SELTZKDLEPWOFA-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
21.9967 -1.8572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9956 -2.6768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7036 -3.0857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4133 -2.6763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4104 -1.8536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7018 -1.4484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1216 -3.0838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1229 -3.9010 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.8287 -2.6741 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5370 -3.0815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5337 -3.8972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2412 -4.3046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9493 -3.8948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9453 -3.0734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2372 -2.6697 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6510 -2.6612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6581 -4.3014 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
21.2875 -3.0848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5801 -2.6756 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.2869 -3.9020 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.5742 -3.4875 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
14 16 1 0
13 17 1 0
2 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 360.13 | Molecular Weight (Monoisotopic): 358.9881 | AlogP: 3.82 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.73 | CX Basic pKa: ┄ | CX LogP: 3.21 | CX LogD: 3.21 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.89 | Np Likeness Score: -1.72 |
References
1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH.. (2017) Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms., 27 (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063] |